Skin Health and Effectiveness of Standardized Skin Care Regimens in Nursing Home Residents

Exclusion Criteria

• •"Prevalence study"
• •Residents at the end of life (dying persons).
• •Any dermatological condition or skin affection, e.g. acute weeping, excoriated or inflammatory dermatitis, or skin treatment which may interfere with the study assessments at the discretion of the investigator;
• •Any unstable acute or chronic pathology or condition that may interfere with the study conduct at the discretion of the investigator;
• •Any use of topical drugs on the investigational areas two weeks prior to inclusion;
• •Systemic application of corticosteroids, antihistamine or other anti-inflammatory drugs;
• •Known allergy or intolerance to any ingredient of the study products, e.g. urea.